| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -1.5 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |